Market closed
MIRA Pharmaceuticals Inc./$MIRA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
Ticker
$MIRA
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
-
Website
MIRA Metrics
BasicAdvanced
$16M
-
-$0.51
-
-
Price and volume
Market cap
$16M
52-week high
$1.33
52-week low
$0.73
Average daily volume
1.9M
Financial strength
Current ratio
3.992
Quick ratio
3.916
Management effectiveness
Return on assets (TTM)
-127.59%
Return on equity (TTM)
-238.90%
Valuation
Price to book
7.07
Price to tangible book (TTM)
7.07
Price to free cash flow (TTM)
-2.608
Growth
Earnings per share change (TTM)
-40.91%
3-year earnings per share growth (CAGR)
43.59%
MIRA News
AllArticlesVideos
MIRA Pharmaceuticals Announces Positive Results for Ketamir-2 in Diabetic Neuropathy Animal Model, Reinforcing Confidence Ahead of Phase I Completion
Accesswire·3 days ago
MIRA Pharmaceuticals Signs Binding Letter of Intent to Acquire SKNY Pharmaceuticals, Securing a $5 Million Capital Infusion to Advance Weight Loss and Smoking Cessation Drug Development
Accesswire·4 weeks ago
MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic and Inflammatory Pain
Accesswire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for MIRA Pharmaceuticals Inc. stock?
MIRA Pharmaceuticals Inc. (MIRA) has a market cap of $16M as of April 19, 2025.
What is the P/E ratio for MIRA Pharmaceuticals Inc. stock?
The price to earnings (P/E) ratio for MIRA Pharmaceuticals Inc. (MIRA) stock is 0 as of April 19, 2025.
Does MIRA Pharmaceuticals Inc. stock pay dividends?
No, MIRA Pharmaceuticals Inc. (MIRA) stock does not pay dividends to its shareholders as of April 19, 2025.
When is the next MIRA Pharmaceuticals Inc. dividend payment date?
MIRA Pharmaceuticals Inc. (MIRA) stock does not pay dividends to its shareholders.
What is the beta indicator for MIRA Pharmaceuticals Inc.?
MIRA Pharmaceuticals Inc. (MIRA) does not currently have a Beta indicator.